UOC project aims to develop a digital solution to evaluate depression apps for patients
Diagnoses of depression, one of the most common mental disorders, increased by nearly 50% between 1990 and 2017, according to data from the World Health Organization (WHO). Currently, depression affects
Personalised & optimised therapy (POT) algorithm using five cognitive and behavioural skills for subthreshold depression
The protocol paper16 and the primary analysis paper17 provide detailed information about the RESiLIENT trial (UMIN Clinical Trials Registry UMIN000047124, registered on 1 August 2022). The study was approved by